MicroPort Orthopedics Optimizing Episodes of Care Company Updates A partnership with PatientIQ will provide an experience that can be specifically tailored to a procedure or a diagnosis. May 27, 2021
Preparing for the Next Big Orthopedic Supply Chain Interruption Actionable Advice OEM and contract manufacturer executives share that businesses can prepare for disruptions by fostering resilient plans, leadership and teams. May 20, 2021
Anika Therapeutics Organic Growth Can’t Offset Viscosupplement Declines Company Revenue The company declined in the mid-single digits due to COVID-related headwinds and inventory stocking declines in its orthobiologics franchise. May 11, 2021
Conformis Near-Term Growth Hinges on Intellectual Property Company Revenue The company declined in the mid-teens for 1Q21 but hopes to return to product revenue growth above 2019-levels by the end of the year. May 10, 2021
Conformis Gains FDA Clearance for Identity Imprint Knee Replacement Joint Replacement Identity Imprint is designed to match patients’ anatomy while offering efficiency, cost savings, intraoperative flexibility and faster delivery. May 10, 2021
NuVasive Benefits from International Recovery in 1Q21 Company Revenue The company grew in the mid-single-digits for the first quarter, as recovery in global markets offset some choppiness in the U.S. May 07, 2021
Zimmer Biomet Continues Technology Evolution in First Quarter Company Revenue The company grew in the low single-digits for 1Q21, with important contributions from ROSA and its Signature ONE shoulder planner. May 06, 2021
SI-BONE Rides Record March Revenues for First Quarter Growth Company Revenue The company realized around 40% of its first-quarter sales in March to overcome COVID and weather-related declines for 1Q21. May 05, 2021
Smith+Nephew Begins 2021 with Double-Digit Orthopedic Growth Company Revenue The company’s orthopedic revenue grew 11% in 1Q21, driven by strength in its hip, sports medicine and robotics franchises. May 04, 2021
Orthofix Expects COVID Headwinds Through Second Quarter Company Revenue The company grew less than 1% in 1Q21, driven by its M-6 disc and interbody portfolio. Orthofix sees COVID headwinds lasting through 1H21. May 03, 2021